Left ventricular size and function after subcutaneous administration of terbutaline

Area of Science:

• Cardiology
• Pharmacology

Background:

• Previous myocardial infarction can lead to impaired left ventricular function.
• Beta-2 adrenergic agonists are investigated for their potential cardiovascular effects.

Purpose of the Study:

• To evaluate the left ventricular response to subcutaneously administered terbutaline sulfate.
• To determine if terbutaline sulfate has differential effects based on baseline left ventricular function.

Main Methods:

• Equilibrium radionuclide angiography was used to assess cardiac function in 12 post-myocardial infarction patients.
• Patients were divided into two groups based on resting global left ventricular ejection fraction.
• Hemodynamic parameters including ejection fraction, end-diastolic volume, end-systolic volume, cardiac output, and systemic vascular resistance were measured.

Main Results:

• All patients showed improved ejection fraction and reduced ventricular volumes post-terbutaline administration.
• Cardiac output increased by 30% in patients with depressed function (group 2) due to increased stroke volume.
• Patients with compensated heart failure experienced a greater decrease in systemic vascular resistance compared to those with normal function.

Conclusions:

• Terbutaline sulfate demonstrates a beneficial effect on left ventricular function, especially in patients with depressed baseline function.
• The beta-2 selective agonist may be a potential therapeutic agent for managing congestive heart failure.